GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canntab Therapeutics Ltd (STU:TBF1) » Definitions » PB Ratio

Canntab Therapeutics (STU:TBF1) PB Ratio : (As of Jun. 22, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Canntab Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-22), Canntab Therapeutics's share price is €0.184. Canntab Therapeutics's Book Value per Share for the quarter that ended in Feb. 2023 was €-0.04. Hence, Canntab Therapeutics's PB Ratio of today is .

The historical rank and industry rank for Canntab Therapeutics's PB Ratio or its related term are showing as below:

STU:TBF1's PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.895
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Canntab Therapeutics PB Ratio Historical Data

The historical data trend for Canntab Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canntab Therapeutics PB Ratio Chart

Canntab Therapeutics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 May17 May18 May19 May20 May21 May22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 7.67 8.59 15.23 -

Canntab Therapeutics Quarterly Data
Mar18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.95 - - - -

Competitive Comparison of Canntab Therapeutics's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Canntab Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Canntab Therapeutics's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Canntab Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Canntab Therapeutics's PB Ratio falls into.



Canntab Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Canntab Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Feb. 2023)
=0.184/-0.039
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Canntab Therapeutics  (STU:TBF1) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Canntab Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Canntab Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Canntab Therapeutics (STU:TBF1) Business Description

Traded in Other Exchanges
N/A
Address
1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.

Canntab Therapeutics (STU:TBF1) Headlines

No Headlines